Skip to main content
NMAD logo

NMAD

Lixte Biotechnology Holdings, Inc.
$6.93 +0.83 (+13.61%) At close · Jul 8
Market Cap
$85.81M
Shares
12,382,944

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-06-11 4,024 $6.89 $27,725
2026-06-09 234 $6.65 $1,556
2026-06-08 3,153 $7.00 $22,071
2026-06-05 63,104 $7.00 $441,728
2026-06-04 17,137 $6.71 $114,989
2026-06-03 4,663 $7.04 $32,828
2026-06-02 53,505 $7.21 $385,771
2026-06-01 5,554 $6.25 $34,713
2026-05-29 1,463 $5.99 $8,763
2026-05-28 11 $6.42 $71
2026-05-27 1,860 $5.65 $10,509
2026-05-26 1,345 $5.88 $7,909
2026-05-19 3,149 $4.70 $14,800
2026-05-18 196 $5.16 $1,011
2026-05-15 4,853 $5.04 $24,459
2026-05-13 5,234 $5.07 $26,536
2026-05-12 40,001 $5.12 $204,805
2026-05-11 2,000 $5.16 $10,320
2026-05-08 2,000 $4.93 $9,860
2026-05-07 2,477 $4.40 $10,899
2026-05-05 1,036 $3.29 $3,408
2026-04-30 351 $3.50 $1,229
2026-04-24 4,069 $3.98 $16,195
2026-04-22 74 $3.39 $251
2026-04-20 179 $3.61 $646
2026-04-13 3,840 $3.05 $11,712
2026-04-09 49 $2.85 $140
Showing 1–27 of 27 settlements
Key facts CIK 1335105 CUSIP 539319301 13F (30d) 2 filings 2 filers Visit website Investor relations